Elamipretide does not have anything to do with astigmatism or presbyopia, a condition when people over 40 years old have difficulty reading close print. Raj Maturi, MD, clinical spokesperson for the American Academy of Ophthalmology and ophthalmologist at Midwest Eye Institute, stresses that SS-31 is not an established treatment for common vision issues like myopia (nearsightedness), presbyopia, or astigmatism.Those problems are optical and structural, explains Dr
Meanwhile, tirzepatide participants lost body weight by 16%, 21.4%, and 22.5% on 5 mg, 10 mg, and 15 mg (once weekly injections), respectively, after 72 weeks
Were delighted to hear that you found our service professional, friendly, and efficient
Kato S, Funakoshi H, Nakamura T, Kato M, Nakano I, et al